Top Markets
#1 Islamic Coin Islamic Coin +158.25%
#2 Glidr Glidr +58.56%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.53%
#4 Movement Movement +10.52%
#5 Palladium Network Palladium Network +8.73%
#6 Pons Pons +7.33%
#7 Cryptopia Cryptopia +6.10%
#8 Victoria VR Victoria VR +5.49%
#9 DMT-NAT DMT-NAT +5.17%
#10 Lisk Lisk +4.83%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Panacos Pharmaceuticals, Inc. Panacos Pharmaceuticals, Inc.

Panacos Pharmaceuticals, Inc.

PANC
Rank in Stocks #42054
Panacos Pharmaceuticals, Inc. functions as an early-stage biotechnology firm... Panacos Pharmaceuticals, Inc. functions as an early-stage biotechnology firm specializing in the research and development of orally administered small-molecule therapeutics. These innovative drugs are crafted to combat human immunodeficiency virus (HIV) and various other viral diseases affecting humans. The company's scientific methodology concentrates on identifying novel targets within the viral life cycle, specifically focusing on processes like virus maturation and fusion. Currently, their product portfolio includes advanced initiatives, such as second- and third-generation programs, centered on inhibiting HIV maturation. Founded in 1999, the company's main operations are situated in Watertown, Massachusetts.
Share Price
$0.0001
Last synced: 2026-08-11
Market Cap
$5.37K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Panacos Pharmaceuticals, Inc. (PANC)

Category

Healthcare
Number of shares outstanding for Panacos Pharmaceuticals, Inc. (PANC)
Number of shares outstanding as of August 2026: 0
According to Panacos Pharmaceuticals, Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Panacos Pharmaceuticals, Inc. (PANC) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR